Broad Antiviral Activity of Carbohydrate-Binding Agents against the Four Serotypes of Dengue Virus in Monocyte-Derived Dendritic Cells

A Complex Interplay among Virus, Dendritic Cells, T Cells, and Cytokines in Dengue Virus Infections

(2014) W. Dejnirattisai et al.   JOURNAL OF IMMUNOLOGY

Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use

(2010) J. Balzarini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope

(2010) B. Hoorelbeke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

(2010) W. Dejnirattisai et al.   SCIENCE

Immunogenicity of sanofi pasteur tetravalent dengue vaccine

(2009) Bruno Guy   JOURNAL OF CLINICAL VIROLOGY

N-Linked glycans on dengue viruses grown in mammalian and insect cells

(2009) K. Hacker et al.   JOURNAL OF GENERAL VIROLOGY

Modulation of Cellular Tropism and Innate Antiviral Response by Viral Glycans

(2009) Kristin M. Rogers et al.   Journal of Innate Immunity

A Yeast Glycoprotein Shows High-Affinity Binding to the Broadly Neutralizing Human Immunodeficiency Virus Antibody 2G12 and Inhibits gp120 Interactions with 2G12 and DC-SIGN

(2009) R. J. Luallen et al.   JOURNAL OF VIROLOGY

Mechanism by which the lectin actinohivin blocks HIV infection of target cells

(2009) H. Tanaka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection

(2009) Marijke M.F. Alen et al.   VIROLOGY

Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy

(2009) Monika Simmons et al.   VIROLOGY

The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways

(2008) A. A. Lambert et al.   BLOOD

Understanding the contribution of cellular immunity to dengue disease pathogenesis

(2008) Anuja Mathew et al.   IMMUNOLOGICAL REVIEWS

Simian Immunodeficiency Virus Is Susceptible to Inhibition by Carbohydrate-Binding Agents in a Manner Similar to That of HIV: Implications for Further Preclinical Drug Development

(2008) K. O. Francois et al.   MOLECULAR PHARMACOLOGY

The Mannose Receptor Mediates Dengue Virus Infection of Macrophages

(2008) Joanna L. Miller et al.   PLoS Pathogens

Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus

(2008) Peifang Sun et al.   VIROLOGY

Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes

(2007) M. Pollicita et al.   VIROLOGY